In 2006, a congressionally requested committee was appointed by the Institute of Medicine to review pharmaceutical safety regulation in the U.S. and to issue recommendations for improvements.
2006年，一个国会要求的、由美国医学研究所（Institute of Medicine）委任的委员会对美国药品安全性的监管进行了审查并提出了改进建议。